DAVA Oncology Information

Three Specialties, One Focus DAVA Oncology Optimize the recruitment and retention of patients in cancer clinical trials through the use of physician-focused approaches. DAVA has a proven track record having completed more than 45 Phase I to III trials and over the past six years with an average accrual enhancement rate of 30-40%. ONE Oncology Improve drug development understanding and decision-making through the consolidation and dissemination of cancer knowledge. Oncology Meeting Innovations (OMI) Conduct interactive meetings in today’s clinical environment connecting academic and community oncologists.

Website	http://www.davaonc.com
Revenue	$6 million
Employees	40 (2 on RocketReach)
Founded	2007
Address	5420 Lbj Fwy, Ste 410, Dallas, Texas 75240, US
Phone	+1 214-207-8003
Technologies	JavaScript , HTML , PHP +38 more (view full list)
Industry	Pharmaceutical Manufacturing, Medical Testing & Clinical Laboratories, Biotechnology, Strategic Consulting, Healthcare, Science and Engineering, Oncology, Marketing, Cancer Research, Sales and Marketing, Physician-Focused Patient Recruitment, Medical, Clinical Trial Acceleration, Health Care, Scientific Exchange Programs, Pharmaceutical
Web Rank	16 Million
Keywords	Cancer Clinical Trials, Patient Recruitment, Patient Retention, Oncology Clinical Research, Physician Engagement, Clinical Trial Optimization, Drug Development, Cancer Research, Oncology, Healthcare, Pharmaceutical, Biotech, Clinical Trial Management, Medical Research, Therapeutic Trials, Cancer Treatment, Oncology Research, Trial Recruitment, Healthcare Research
Competitors	National Cancer Institute (NCI), Genentech, Bristol Myers Squibb, Amgen, Merck & Co., Inc., Pfizer, Roche, Novartis, AstraZeneca, Eisai Co., Ltd. +47 more (view full list)
SIC	SIC Code 28 Companies, SIC Code 283 Companies
NAICS	NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies